{"path":"Images/Pasted image 20231007140751.png","text":"onepagericu.com Linktothe EVASE[E] & nathan D 5 B PULMONARY-RENAL SYNDROMES by Nick Mark o & Mithu Maheswaranathan ‘ ONE | wonidmmake oo 3 PRESENTATION: WORKUP & DIAGNOSIS Welihukhen verson > \" Pulmonary Renal Syndromes (PRS) are life-threatening Labs: U T = o8 diseases with pulmonary hemorrhage (DAH) & rena falure + BMP (quantifyrenal njury), Coags (/o cosgulopathy) ARV or Goodpasture's cause pulmonary capilarits eading (glomerulonephrits). Although pulmonary and renal + CBC wifferentia (check eosinophil count for EGPA) to iffuse alveolar hemorrhage (DAH) involvement s the defining feature, PRS can affect many organs: + ~ Auto-antibodies: ANCA antibod, Ant-GBM antibody - Diffuse ground glass or consolidative opacites with sparing scuterespctoryflure jomenuionephets: + Urine: UA, Urine protein to creatinine (UPC) ratio orthe lung periphery i typically seen on chest CT. piratory 8le slonept ° ! \" or the lung periphery is typi ordiffuse aheolar acute kidney njury (a), + Cardiac: consider BN, troponin if concern for EGPA ~BAL revealsincreasing blood return in seril lavages and hemorthage (0AH) proteinuria, hematuria +ESR and CRP (non-specfic ESR usually low in ant-GBM) >20% hemosiderin aden macrophages (diagnostic of DAH) phages (diag Other tests: Lavage #1 Lavage #2 Lavage #3 nflammatory @) ENT:inus, nasal,hearing os5, + CTchest to evaluate pulmonary involvement BALGf airways eye disease saddle nose deformity « Bronchoscopy: confirm DAH, r/o infection and alveol sclerits, uveitis, « Echocardiogram for EGPA ({, LVEF, pericardial effusion) e e e | Y o - EMG/NCS for mononeuritis multiplex/neuropathy. lavages cardac ouloonary module,astma EGPA) Diagnosis of PRS: biopsy (gold standard) or serologies + “dear (in EGPA) symptoms (not-optimal but may be necessary) _ slomeruloneprits (3, G digital ischeinia proteinuria, hematuria) AuTe t g © MPA-rusalypANCA - Goodpasture’s antiGaM cutaneous |~ neuropathy, mononeuritis o GPAmusuallycANCA - ‘Subsequent lavages reach more distal airways & alveoli J palpabe purpura e + EGPA—» ANCAIn 40.50% . . . 22 vasculis, multp! MOVocVsalisi) - Surgical lung biopsy (not always required) may reveal: icers,nodues &) “on B -linearIgG staiing along BM (ontiGEV) Pulmonary & (. Ao - granular immune complex deposition (SLE & theum dx) DIFFERENTIAL DIAGNOSIS: Renal failure. d o o wx ax - Pauciimmune (nolg immune complex) with neutrophil CANCA (MPO) infiltration of vessels (GPA) or eosinophils (EGPA). - G v ¥ 2 v omacne | aNCA OTHER FINDINGS: o other [r—— o oo iie ey 1% 8% 8% 3% Giniecions:palpable purpura, petechiae, ulcerations, & E . | ™ e - ‘occasionally nodules. Nasalor sinus mucosa often involved nuclear i . i ue I . - nbeorgamsms P xanca TR EGPA. lopsy of kinor sl mucsacan-eve e I ole v trenmt tatoe: Soimn Levamcoeloomne, marmaane vascullts such as leukocytodlasic vasculits of skin ogibuinemia ydloane epaspods antavis, £ G0 WM ANCAdkoseonmanydsesses APPROACH: it x focusedon emission-induction Satemicscieross - minocycine T8, M, Legionella IS, o) S RAPSC PBC AN, 8D (UC>CD) Later tx focused on maintenance. * HSP & IgA vasculitis - others. -Postinfections (g RENAL FINDINGS: 9 Linear BM Pauci-immune post-strep GN) 'U/A: microscopic or gross hematuria, RBC 2 o o, PHABLAK) pic or g 2 deposition crescentic GN (e casts, low grade proteinuria v v Path: rapidly progressive (crescentic) v — v Autoimmune ANCA vasculitis Anti-basement membrane ‘glomerulonephritis (fibrinoid necrosis, g ANCA() ANCA(+) ANCA () (aav) (Goodpasture) hypercellular glomerul, & cellular crescents) © Gam (+) GBM (+) GBM () + GPA (granulomatous with polyangiitis) IF staining patterns in ntic GN: ANTI-GBM DISEASE RLAS R ANCAvascuums 9 £GP (eosinophll: granulomatoss w polyangiis) Lo pATTERN CRANULAR PATTERN. PAUG N z spese o Ao 3 ¢ P8 (merescopicpolyangiiis) Plasmapheresis (PLEX) pulse dose serolds E PATHOPHYSIOLOGY: Z B froimabandor 3 - AAV: ANCA activates primed neutrophils -» vessel endothelial > g Cyclophosphamide o B damage & inflammation; Granulomatous inflammation (cell- X pulsedose steroids TR H mediated immunity) in some forms of AAV (GPA, EGPA) . v v 2 - GBM: Auto-antibodies against a3 chain of type IV collagen, g LinearlgG saningon Complementeposis Asenc of s = = g distrupting the basement membrane ntegrity in lungs and Kihey. brcneremerirines mdersseer | ens A G, emsltnslant pssoanes 3 - Environmental risk factors: silica exposure (AAV), smoking (GBM) seeninanti-G8Mdx SLE, poststrepGN, and EGPA] evaluation rapy El","libVersion":"0.3.2","langs":"eng"}